WallStSmart
THAR

Tharimmune Inc.

NASDAQ: THAR · HEALTHCARE · BIOTECHNOLOGY

$3.23
+3.53% today

Updated 2026-04-30

Market cap
$177.09M
P/E ratio
P/S ratio
EPS (TTM)
$-3.68
Dividend yield
52W range
$1 – $9
Volume
0.6M

WallStSmart proprietary scores

17
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
5.0
Quality
C+
3.0
Profitability
D
5.0
Valuation
C+
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
$5.00
+54.80%
12-Month target
Intrinsic (DCF)
Margin of safety

Price chart

X-Ray snapshot

Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-1.86M

Key financials

Revenue Net Income Free Cash Flow
Metric2021202220232024TTM
Revenue$0.00$0.00$0.00$0.00$0.00
Net income$-2.21M$-8.47M$-9.32M$-12.20M$-2.10M
EPS$-3.68
Free cash flow$-1.09M$-6.56M$-7.30M$-10.90M$-1.86M
Profit margin

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
THAR$177.09M174.33.05.05.0Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$336.47B545.35.57.34.8+42.09%Buy
AZN$287.11B646.78.05.35.0+4.07%Buy

Smart narrative

Tharimmune Inc. trades at $3.23. Our Smart Value Score of 17/100 indicates the stock is weak.

Frequently asked questions

What is Tharimmune Inc.'s stock price?
Tharimmune Inc. (THAR) trades at $3.23.
Is Tharimmune Inc. overvalued?
Smart Value Score 17/100 (Grade F, Strong Sell).
What is the price target of Tharimmune Inc. (THAR)?
The analyst target price is $5.00, representing +54.8% upside from the current price of $3.23.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio
ROE-2.25%
Beta1.45
50D MA$3.23
200D MA$2.60
Shares out0.04B
Float0.03B
Short ratio
Avg volume0.6M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years